Switching test from latanoprost to travoprost/timolol ophthalmic solution

Switching test from latanoprost to travoprost/timolol ophthalmic solution - Switching test to travoprost/timolol ophthalmic solution

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005062

Enrollment

Registered

2011-02-13

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary open angle glaucoma and ocular hypertension

Interventions

Swtiching from latanoprost ophthalmic solution to travoprost/timolol ophthalmic solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Need anti-glaucoma therapy

Exclusion criteria

Exclusion criteria: active ocular diseases, severe heart and pulmonary diseases, history of allergy against employed ophthalmic solutions, less than six months after any incisional ocular surgery and ocluar trauma, and any other conditions that doctor recognizes inadequate for enrollment

Design outcomes

Primary

Measure	Time frame
intra ocular pressure, blood pressure, pulse rate, corneal erosion, hyperemia	—

Countries

Japan

Contacts

Public ContactKazumi Okudaira

University of Yamanashi Community and Family Medicine

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026